🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "specific steps to tackle household expense issues" in the forthcoming financial statement.

During an interview with the BBC, she stated that lowering inflation is a collective task of both the administration and the Bank of England.

The UK's price growth is forecast to be the highest among the G7 advanced economies this calendar year and next.

Possible Energy Bill Measures

Sources suggest the administration could take action to bring down utility costs, such as by reducing the current 5% level of VAT charged on energy supplies.

Another possibility is to reduce some of the government charges currently included in household expenses.

Budgetary Limitations and Expert Expectations

The government will obtain the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much scope there is for these actions.

The view from the majority of economists is that the Chancellor will have to introduce tax rises or budget cuts in order to meet her declared borrowing rules.

Previously on the same day, calculations suggested there was a £22 billion shortfall for the Treasury chief to fill, which is at the lower end of projections.

"There's a joint task between the Bank of England and the government to bear down further on some of the sources of price increases," the Chancellor informed the BBC in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Commitments and Global Issues

While much of the attention has been on expected tax increases, the chancellor said the most recent information from the OBR had not changed her vow to election pledges not to increase rates on income tax, sales tax or National Insurance.

She attributed an "unpredictable world" with growing international and trade issues for the Budget revenue measures, probably to be directed on those "with the broadest shoulders."

Global Economic Disputes

Addressing worries about the UK's economic relations with China she said: "The UK's security interests invariably take priority."

Last week's statement by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to propose an additional 100% tariff on imports from the Asian country, raising the risk of an full-scale trade war between the two global powers.

The American finance chief labeled China's move "commercial pressure" and "a global supply chain power grab."

Asked about considering the American proposal to join its dispute with China, Reeves said she was "very concerned" by Chinese measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "damaging for the world economy and causes further obstacles."

"It is my opinion there are sectors where we must confront China, but there are also important opportunities to trade with China's economy, including financial services and other areas of the economic system. We've got to maintain that equilibrium appropriate."

The Treasury chief also affirmed she was working with other major economies "regarding our own critical minerals approach, so that we are less reliant."

Health Service Drug Pricing and Funding

The Chancellor also acknowledged that the cost the NHS pays for pharmaceuticals could rise as a result of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping operations in the UK, with some blaming the low prices they are obtaining.

Recently, the government science advisor said the cost the health service pays for drugs would need to increase to prevent companies and drug research funding leaving the UK.

The Chancellor stated to the BBC: "We have seen as a result of the payment system, that medical research, innovative medicines have not been available in the United Kingdom in the extent that they are in other continental states."

"Our aim is to guarantee that patients receiving treatment from the NHS are can obtain the finest life-saving drugs in the globe. And so we are examining all of that, and... looking to secure increased capital into Britain."